Consolidated Balance Sheets (USD $)	Jun. 30, 2012	Dec. 31, 2011
Current Assets
Cash and cash equivalents	$ 2,112,582	$ 3,935,160
Accounts receivable trade, net of allowance for doubtful accounts of $448,487 and $187,600, respectively	1,256,640	1,010,475
Inventory	1,161,343	647,745
Prepaids and other current assets	882,800	649,739
Assets related to discontinued operations	46,838,739	32,367,217
Total current assets	52,252,104	38,610,336
Property, plant and equipment, net	11,301,963	11,616,053
Goodwill	11,117,770	11,117,770
Intangible assets, net	14,783,433	15,086,038
Other assets	3,507,266	3,326,938
Assets related to discontinued operations	45,063,647	75,570,645
Assets, Total	138,026,183	155,327,780
Current Liabilities
Accounts payable	2,171,484	2,287,201
Accrued liabilities	2,108,522	1,090,176
Notes payable	154,978	148,062
Mortgages payable	3,541,306	3,635,061
Unearned revenues	1,631,480	1,121,134
Liabilities related to discontinued operations	38,407,500	28,165,010
Total current liabilities	48,015,270	36,446,644
Long-term Liabilities
Deferred income taxes	3,774,655	3,774,655
Unearned revenues	156,466	169,198
Notes payable	57,057	0
Derivative liabilities	362,946	474,463
Acquisition-related contingent consideration	3,130,000	3,130,000
Other long-term liabilities	70,528	0
Liabilities related to discontinued operations	27,026,259	26,388,976
Total long-term liabilities	34,577,911	33,937,292
Commitments and Contingencies
Redeemable Securities
Convertible Redeemable Series E Preferred Stock; 10,582,011 shares designated, liquidation value $1.00 per share; issued and outstanding 4,311,190 and 6,662,748 shares, at June 30, 2012 and December 31, 2011, respectively	3,574,431	4,811,326
Shareholders' Equity
Preferred stock; authorized, 20,000,000 shares Series B convertible redeemable preferred stock liquidation value, 1 share of common stock, $.01 par value; 825,000 shares designated; issued and outstanding, 10,000 shares at June 30, 2012 and December 31, 2011	100	100
Common stock, $.001 par value, authorized 500,000,000 shares; issued and outstanding, 137,619,903 and 109,329,587 shares, at June 30, 2012 and December 31, 2011, respectively	137,620	109,330
Additional paid-in capital	215,184,988	200,858,638
Accumulated deficit	(173,144,555)	(143,094,854)
Accumulated other comprehensive income	4,174,332	4,152,343
Total NeoStem, Inc. shareholders' equity	46,352,485	62,025,557
Noncontrolling interests	5,506,086	18,106,961
Total equity	51,858,571	80,132,518
Liabilities and Equity, Total	$ 138,026,183	$ 155,327,780